Otopathology in congenital toxoplasmosis

Otology and Neurotology

Volumn 34, Issue 6, 2013, Pages 1165-1169

  Salviz, Mehti ^a,b   Montoya, Jose G ^c,d   Nadol, Joseph B ^a,b   Santos, Felipe ^a,b  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c PALO ALTO MEDICAL FOUNDATION   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hearing loss; Histopathology; Temporal bone; Toxoplasmosis

Indexed keywords

ARTICLE; AUTOPSY; CASE REPORT; COCHLEA; CONGENITAL TOXOPLASMOSIS; EAR DISEASE; FATALITY; HAIR CELL; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MIDDLE EAR; NERVE CELL; NEUTROPHIL; NEWBORN; PATHOLOGY; PERCEPTION DEAFNESS; TEMPORAL BONE; VESTIBULE; COMPLICATION; EAR DISEASES; HEARING LOSS, SENSORINEURAL;

AUTOPSY; COCHLEA; EAR DISEASES; EAR, MIDDLE; FATAL OUTCOME; HAIR CELLS, AUDITORY; HEARING LOSS, SENSORINEURAL; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; MALE; NEURONS; NEUTROPHILS; SACCULE AND UTRICLE; TEMPORAL BONE; TOXOPLASMOSIS, CONGENITAL;

EID: 84881376652     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e31828297b6     Document Type: Article

References (13)

1. Jones JL, Kruszon-Moran D, Wilson M, et al. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 2001;154:357-65.
2. Lopez A, Dietz VJ, Wilson M, et al. Preventing congenital toxo-plasmosis. MMWR Recomm Rep 2000;49:59-68.
3. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004;363: 1965-76. Review.
4. Brown ED, Chau JK, Atashband S, et al. A systematic review of neonatal toxoplasmosis exposure and sensorineural hearing loss. Int J Pediatr Otorhinolaryngol 2009;73:707-11. Review.
5. Schuknecht HF. Pathology of the Ear, 2nd ed. Philadelphia, PA: Lea and Febiger, 1993:7-30. 417-419.
6. O'Malley JT, Burgess BJ, Jones DD, et al. Techniques of celloidin removal from temporal bone sections. Ann Otol Rhinol Laryngol 2009;118:435-41.
7. Eichenwald HF. A study of congenital toxoplasmosis, with particular emphasis on clinical manifestation, sequalae, and therapy. In: Siim JC, ed. Human Toxoplasmosis. Copenhagen, Denmark: Munksgaard, 1960:41.
8. Wilson CB, Remington JS, Stagno S, et al. Development of adverse squeal in children born with subclinical toxoplasma infection. Pediatrics 1980;66:767-73.
9. Andrade GM, Resende LM, Goulart EM, et al. Hearing loss in congenital toxoplasmosis detected by newborn screening. Braz J Otorhinolaryngol 2008;74:21-8.
10. Kelemen G. Toxoplasmosis and congenital deafness. Arch Otolaryngol 1958;68:547-61.
11. Skariah S, McIntyre MK, Mordue DG. Toxoplasma gondii: determinants of tachyzoite to bradyzoite conversion. Parasitol Res 2010;107:253-60. Review.
12. McLeod R, Boyer K, Karrison T, et al. Toxoplasmosis Study Group. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis 2006;42:1383-94.
13. McGee T, Wolters C, Stein L, et al. Absence of sensorineural hearing loss in treated infants and children with congenital toxo-plasmosis. Otolaryngol Head Neck Surg 1992;106:75-80.